Screening the Medicines for Malaria Venture "Malaria Box" against the Plasmodium falciparum aminopeptidases, M1, M17 and M18.
about
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and BeyondIdentification and Validation of a Potent Dual Inhibitor of the P. falciparum M1 and M17 Aminopeptidases Using Virtual ScreeningScreening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar EchinococcosisBilayer Effects of Antimalarial CompoundsBiological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathwayIn Vitro Screening of the Open-Source Medicines for Malaria Venture Malaria Box Reveals Novel Compounds with Profound Activities against Theileria annulata SchizontsMetabolomics-Based Screening of the Malaria Box Reveals both Novel and Established Mechanisms of Action.Characterization of aspartyl aminopeptidase from Toxoplasma gondii.Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways.Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery.Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry.Metallopeptidases of Toxoplasma gondii: in silico identification and gene expression.
P2860
Q27826351-7C06512E-FD52-4A33-B345-280A848592A5Q28548496-4A324C10-BFED-4219-8034-BBF388E5247EQ28550703-A6BAC2F9-8BB8-495F-98E2-06139F0B504CQ28550778-CEDE9B8A-6DAF-415B-B29A-3C48BFA106EEQ28821118-F4FD9100-AA8D-4DC6-8055-07FB05CC524AQ30489095-1E911C6B-F915-4DD1-9E7D-68AAB0C1C6A1Q36116227-1850DF4C-13D4-4C5C-91D0-596C5852D1D5Q37291149-D71D6967-CCD9-492E-8E08-4026803DCAC8Q37358648-6B8BB961-7C66-416F-BC6B-4D833B5ABE68Q38695331-157D4C1A-D25F-4C0C-BA63-B77D27375C50Q50047043-B777CBC6-434A-4F70-B84E-48110AAA83C2Q55283527-B849BF08-AC39-4B30-9940-00F5A92DFAEB
P2860
Screening the Medicines for Malaria Venture "Malaria Box" against the Plasmodium falciparum aminopeptidases, M1, M17 and M18.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Screening the Medicines for Ma ...... nopeptidases, M1, M17 and M18.
@ast
Screening the Medicines for Ma ...... nopeptidases, M1, M17 and M18.
@en
type
label
Screening the Medicines for Ma ...... nopeptidases, M1, M17 and M18.
@ast
Screening the Medicines for Ma ...... nopeptidases, M1, M17 and M18.
@en
prefLabel
Screening the Medicines for Ma ...... nopeptidases, M1, M17 and M18.
@ast
Screening the Medicines for Ma ...... nopeptidases, M1, M17 and M18.
@en
P2093
P2860
P50
P1433
P1476
Screening the Medicines for Ma ...... nopeptidases, M1, M17 and M18.
@en
P2093
Alessandro Paiardini
Komagal Kannan-Sivaraman
Rebecca S Bamert
P2860
P304
P356
10.1371/JOURNAL.PONE.0115859
P577
2015-02-20T00:00:00Z